3D Bioprinting Market Size, Share & Trends Analysis Report By Technology (Magnetic Levitation, Inkjet-based), By Application (Medical, Dental, Biosensors, Bioinks), By Region, And Segment Forecasts, 2023 - 2030
3D Bioprinting Market Growth & Trends
The global 3D bioprinting market size is expected to reach USD 5.3 billion by 2030, expanding at a CAGR of 12.5% over the forecast period, according to a new report by Grand View Research, Inc. Rising cases of COVID-19 and high prevalence of chronic diseases are some of the major factors contributing to the growth. During the outbreak of the pandemic, 3D printing has stepped up to become a vital technology to support improved healthcare and emergency response.
The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast-tracked the development of vaccine and drug testing.
In the meantime, various 3D bioprinting companies are focused on the R&D of artificial tissues. With the help of U-FAB and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator.
The pandemic not only affected the well-being of people, but also affected the economy, and various other healthcare infrastructures worldwide. It severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situations, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to healthcare workers.
North America held the highest share of about 30.9% in 2022. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness increased technological development in the pharmaceutical and biopharmaceutical sectors.
3D Bioprinting Market Report Highlights
The medical segment accounted for the largest share of 37.6% in 2022 due to the increasing investment made in R&D
The magnetic levitation segment is anticipated to witness the highest CAGR of 13.7% over the forecast period due to technological development, and increasing adoption of magnetic levitation techniques by various innovators
North America dominated the market in 2022 with a share of 30.9%. Growing government expenditure on the healthcare industry is one of the major factors driving the market in this region
Some of the key players include Organovo; Envision TEC; Inventia Life Science PTY LTD; Poietis; Vivax Bio, LLC; Allevi; Cyfuse Biomedical K.K.; 3D Bioprinting Solutions; Cellink Global; Regemat 3D S.L.
Please note The report will be delivered in 3-8 business days upon order notification.
Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary technology & third party perspectives
1.3.4 Primary research
1.4 Information Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
Chapter 2 Executive Summary
2.1 3D Bioprinting Market Outlook, 2018 - 2030
Chapter 3 Industry Outlook: Market Variables, Trends, & Scope
3.1 Market Segmentation and Scope
3.2 Market Size and Growth Prospects
3.3 3D Bioprinting Market: Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Technological advancement in the 3d bioprinting industry
3.3.1.2 Rising prevalence of chronic disease
3.3.1.3 Increasing use of 3d bioprinting in the pharmaceutical and cosmetology
3.3.2 Market restraint analysis
3.3.2.1 The high cost of 3D bioprinters
3.3.2.2 Lack of trained professionals
3.4 Industry Analysis - Porter’s
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Substitution Threat
3.4.4 New Entrants Threat
3.4.5 Competitive Rivalry
3.5 3D Bioprinting-SWOT Analysis, By PEST
3.5.1 Political landscape
3.5.2 Economic landscape
3.5.3 Social landscape
3.5.4 Technology landscape
3.6 Covid Impact Analysis
Chapter 4 3D Bioprinting Market: Technology Estimates & Trend Analysis
4.1 Global 3D Bioprinting Market: Technology Movement Analysis
4.2 Magnetic Levitation Technology
4.2.1 Global Magnetic Levitation technology market, 2018 - 2030 (USD Million)
4.3 Inkjet-based Technology
4.3.1 Global Inkjet-based technology market, 2018 - 2030 (USD Million)
4.4 Syringe-based Technology
4.4.1 Global Syringe-based technology market, 2018 - 2030 (USD Million)
4.5 Laser-based Technology
4.5.1 Global Laser-based technology market, 2018 - 2030 (USD Million)
4.6 Others
4.6.1 Global Other technologies market, 2018 - 2030 (USD Million)
Chapter 6 3D Bioprinting Market: Application Estimates & Trend Analysis
6.1 Global 3D Bioprinting Market: Application Movement Analysis
6.2 Medical
6.2.1 Global medical market, 2018 - 2030 (USD Million)
6.2.2 Tissue and organ generation
6.2.2.1 Global tissue and organ generation market, 2018 - 2030 (USD Million)
6.2.3 Medical pills
6.2.3.1 Global Medical pills market, 2018 - 2030 (USD Million)
6.2.4 Prosthetics and implants
6.2.4.1 Global Prosthetics and implants market, 2018 - 2030 (USD Million)
6.2.5 Others
6.2.6.1 Global others application market, 2018 - 2030 (USD Million)
6.3 Dental
6.3.1 Global dental market, 2018 - 2030 (USD Million)
6.4 Biosensors
6.4.1 Global biosensors market, 2018 - 2030 (USD Million)